M. M. Bortin
About
In The Last Decade
M. M. Bortin
43 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Hematology 1.4k
- Immunology 671
- Oncology 369
- Public Health, Environmental and Occupational Health 366
- Genetics 329
Countries citing papers authored by M. M. Bortin
This map shows the geographic impact of M. M. Bortin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. M. Bortin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. M. Bortin more than expected).
Fields of papers citing papers by M. M. Bortin
This network shows the impact of papers produced by M. M. Bortin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. M. Bortin. The network helps show where M. M. Bortin may publish in the future.
Co-authorship network of co-authors of M. M. Bortin
This figure shows the co-authorship network connecting the top 25 collaborators of M. M. Bortin. A scholar is included among the top collaborators of M. M. Bortin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. M. Bortin. M. M. Bortin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia. | 69 |
| 2 | 6 | |
| 3 | Progress report from the International Bone Marrow Transplant Registry. | 39 |
| 4 | Allogeneic bone marrow transplants for Fanconi anemia. A preliminary report from the International Bone Marrow Transplant Registry. | 18 |
| 5 | 62 | |
| 6 | Consensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease. Committee of the International Bone Marrow Transplant Registry. | 158 |
| 7 | 57 | |
| 8 | 64 | |
| 9 | Graft-versus-leukemia following bone marrow transplantation. | 127 |
| 10 | 73 | |
| 11 | 9 | |
| 12 | Growth of t-lymphoblastic leukemia cells in vitro using t-cell growth factor. Abstr. | 2 |
| 13 | Graft versus leukemia. VIII. Selective reduction in antihost reactivity without loss of antileukemic reactivity by treatment of donor mice with lipopolysaccharide. | 1 |
| 14 | 8 | |
| 15 | 45 | |
| 16 | Graft-versus-leukemia for AKR spontaneous leukemia-lymphoma. | 6 |
| 17 | 2 | |
| 18 | 1 | |
| 19 | 24 | |
| 20 | BONE-MARROW TRANSPLANTATION IN A PATIENT WITH THE WISKOTT-ALDRICH SYNDROME breakdown → | 607 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.